CLINICAL TRIALS PROFILE FOR RESTASIS MULTIDOSE
✉ Email this page to a colleague
All Clinical Trials for restasis multidose
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00348335 ↗ | Efficacy of Topical Cyclosporin for Ocular Rosacea | Completed | Allergan | Phase 4 | 2006-06-01 | The purpose of this study is to determine whether Restasis (topical cyclosporin) is effective in the treatment of ocular rosacea |
| NCT00348335 ↗ | Efficacy of Topical Cyclosporin for Ocular Rosacea | Completed | Ophthalmic Consultants of Long Island | Phase 4 | 2006-06-01 | The purpose of this study is to determine whether Restasis (topical cyclosporin) is effective in the treatment of ocular rosacea |
| NCT00349440 ↗ | Efficacy of Cyclosporine for the Prevention and Treatment of Dry Eye Symptoms Following LASIK or Photorefractive Keratectomy | Completed | Innovative Medical | Phase 4 | 2006-09-01 | The purpose of this study is to evaluate the effect of topical cyclosporine ophthalmic solution 0.05% (Restasis, Allergan) on the signs and symptoms of dry eye in patients undergoing LASIK or photorefractive keratectomy (PRK). |
| NCT00399061 ↗ | Efficacy of Optive Versus Systane Concomitant With Restasis (Cyclosporine A) for the Treatment of Dry Eye Symptoms | Completed | Innovative Medical | Phase 4 | 2006-11-01 | The purpose of this study is to evaluate the efficacy of Optive versus Systane used concomitantly with topical cyclosporine for the treatment of dry eye. |
| NCT00405431 ↗ | Will Restasis Eye Drops Increase Your Chance of Having a Successful Surgery? | Completed | Allergan | N/A | 2004-03-01 | The purpose of this study is to determine whether reducing inflammation of the surface of the eye with topical Restasis after glaucoma surgery will improve surgical outcomes and increase patient comfort. |
| NCT00405431 ↗ | Will Restasis Eye Drops Increase Your Chance of Having a Successful Surgery? | Completed | Wills Eye | N/A | 2004-03-01 | The purpose of this study is to determine whether reducing inflammation of the surface of the eye with topical Restasis after glaucoma surgery will improve surgical outcomes and increase patient comfort. |
| NCT00405457 ↗ | Efficacy and Safety of a New Multi-dose Lubricant Eye Drop Concomitant With Restasis® (Cyclosporine A) for the Treatment of Dry Eye Symptoms | Completed | Innovative Medical | Phase 4 | 2006-11-01 | To evaluate the efficacy, safety and tolerability of a combination of Optive® Artificial Tears with Restasis®.The primary hypothesis is that the Ocular Surface Disease Index (OSDI) score and symptoms will be the same or lower than baseline after treatment in these patients. The patients will tolerate the combination of Restasis® and Optive® with a low incidence of clinical adverse events. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for restasis multidose
Condition Name
Clinical Trial Locations for restasis multidose
Trials by Country
Clinical Trial Progress for restasis multidose
Clinical Trial Phase
Clinical Trial Sponsors for restasis multidose
Sponsor Name
